Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evolent Health (EVH)
NYSE:EVH
Evolent Health (EVH) Stock Price & Analysis
571 Followers
EVH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.98 - $35.00
Previous Close$19.69
Volume359.94K
Average Volume (3M)1.79M
Market Cap
$2.28B
Enterprise Value$2.77B
Total Cash (Recent Filing)$165.15M
Total Debt (Recent Filing)$643.07M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Aug 08, 2024EPS Estimate
$0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.25
Shares Outstanding116,213,123
10 Day Avg. Volume1,383,068
30 Day Avg. Volume1,789,538
Standard Deviation0.18
R-Squared0.18
Alpha0.00874
Financial Highlights & Ratios
Price to Book (P/B)-3.27
Price to Sales (P/S)1.33
Price to Cash Flow (P/CF)133.20
P/FCF Ratio75.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.27
Enterprise Value/Gross Profit6.01
Enterprise Value/Ebitda-352.96
Forecast
1Y Price Target
$42.86Price Target Upside118.12% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Evolent Health News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceEvolent Health reported 1Q24 results, beating revenue estimates and topping adjusted EBITDA estimate.
New Business OpportunitiesThe recent agreement to acquire certain assets of Machinify and an exclusive license to the Machinify Auth platform leverages artificial intelligence to increase the quality, consistency, and speed of clinical specialty reviews.
Revenue GuidanceThe company raised revenue guidance for the year by 4.7% at the midpoints, with 2Q revenue guidance well above analyst and consensus estimates.
Bears Say
ExpensesHigher estimated medical expenses in 1Q due to diminished visibility from the Change hack provided a headwind to 1Q adj-EBITDA and led to a wide range for 2Q'24 adj-EBITDA guidance.
Financial PerformanceUncertainty as to the timing of potential cost relief has led to a conservative trimming of the 2Q24 EBITDA estimate.
Profit MarginsAdjusted gross margin fell 185 basis points quarter-over-quarter due to higher estimated medical expenses and visibility challenges.
---
Ownership Overview
12.06% Insiders
43.17% Mutual Funds
15.50% Other Institutional Investors
29.27% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EVH FAQ
What was Evolent Health’s price range in the past 12 months?
Evolent Health lowest stock price was $17.98 and its highest was $35.00 in the past 12 months.
What is Evolent Health’s market cap?
Currently, no data Available
When is Evolent Health’s upcoming earnings report date?
Evolent Health’s upcoming earnings report date is Aug 08, 2024 which is in 17 days.
How were Evolent Health’s earnings last quarter?
Evolent Health released its earnings results on May 09, 2024. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.218 by $0.122.
Is Evolent Health overvalued?
According to Wall Street analysts Evolent Health’s price is currently Undervalued.
Does Evolent Health pay dividends?
Evolent Health does not currently pay dividends.
What is Evolent Health’s EPS estimate?
Evolent Health’s EPS estimate is $0.22.
How many shares outstanding does Evolent Health have?
Evolent Health has 116,213,120 shares outstanding.
What happened to Evolent Health’s price movement after its last earnings report?
Evolent Health reported an EPS of $0.34 in its last earnings report, beating expectations of $0.218. Following the earnings report the stock price went down -9.273%.
Which hedge fund is a major shareholder of Evolent Health?
Among the largest hedge funds holding Evolent Health’s share is RA Capital Management. It holds Evolent Health’s shares valued at 188M.
---
Evolent Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$42.86 (118.12% Upside)
$42.86 (118.12% Upside)
Blogger Sentiment
Bullish
EVH Sentiment 66%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 2.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 4.2%
Last 30 Days ▲ 4.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.29%
12-Months-Change
Fundamentals
Return on Equity
-10.17%
Trailing 12-Months
Asset Growth
2.09%
Trailing 12-Months
Company Description
Evolent Health
Evolent Health, Inc. engages in the provision of health care delivery and payment services. Its solutions include population health management, health plan administration and third party administration, network performance management, risk adjustment, pharmacy benefit management, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services segment and True Health segment. The Services segment includes three types of services designed to help partners manage patient health; value-based care services, specialty care management services and comprehensive health plan administration services. The True Health segment, which operates a health plan in New Mexico, and provides reinsurance to NMHC, takes on certain insurance and underwriting costs in pricing its premiums. The company was founded by Frank J. Williams, Seth B. Blackley, and Tom Peterson in August 2011 and is headquartered in Arlington, VA.
---
EVH Company Deck
---
EVH Earnings Call
Q1 2024
0:00 / 0:00
---
EVH Stock 12 Month Forecast
Average Price Target
$42.86
▲(118.12% Upside)
Technical Analysis
Best Analysts Covering EVH
1 Year
1 Year Success Rate
22/46 ratings generated profit
1 Year Average Return
+16.54%
reiterated a buy rating 2 months ago
Copying Richard Close's trades and holding each position for 1 Year would result in 47.83% of your transactions generating a profit, with an average return of +16.54% per trade.
---